Comparative Outcomes of Peripheral Vascular Interventions in Patients on Chronic Anticoagulation with Factor Xa Inhibitors and Vitamin K Antagonists
Huttler J, Alameddine D, Damara F, Rodriguez P, Wu Z, Slade M, Strosberg D, Ochoa Chaar C. Comparative Outcomes of Peripheral Vascular Interventions in Patients on Chronic Anticoagulation with Factor Xa Inhibitors and Vitamin K Antagonists. Annals Of Vascular Surgery 2024, 104: 185-195. PMID: 38493886, DOI: 10.1016/j.avsg.2023.12.092.Peer-Reviewed Original ResearchVitamin K antagonistsPeripheral arterial diseaseChronic anticoagulationLong-term outcomesFactor Xa inhibitorsAmputation-free survivalK antagonistsXa inhibitorsVitamin K antagonist groupMultivariate logistic regression analysisOutcomes of patientsKaplan-Meier analysisCox proportional hazards regressionLong-term followRate of hematomaProportional hazards regressionPeripheral vascular interventionsLogistic regression analysisOptimal regimenPatient demographicsAnticoagulation regimensVenous thromboembolismAtrial fibrillationFXaIProcedural characteristicsThe Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
Alameddine D, Damara F, Pinto Rodriguez P, Huttler J, Slade M, Arhuidese I, Aboian E, Ochoa Chaar C. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Annals Of Vascular Surgery 2024, 103: 47-57. PMID: 38387798, DOI: 10.1016/j.avsg.2023.12.071.Peer-Reviewed Original ResearchImpact of cilostazolPeripheral vascular interventionsPeripheral arterial diseaseTreatment of intermittent claudicationRates of long-term mortalityPeripheral vascular interventional proceduresKaplan-Meier methodCongestive heart failureLong-term mortalityLong-term outcomesEndovascular peripheral interventionsRenal complicationsPatient demographicsBaseline characteristicsHeart failureDiabetes mellitusArtery diseaseIntermittent claudicationCilostazolPatientsVascular interventionsPeripheral interventionsClaudicationOutcomesIntervention